Skip to main content

Application of preoperative advanced diffusion magnetic resonance imaging in evaluating the postoperative recurrence of lower grade gliomas

Abstract

Background

Recurrence of lower grade glioma (LrGG) appeared to be unavoidable despite considerable research performed in last decades. Thus, we evaluated the postoperative recurrence within two years after the surgery in patients with LrGG by preoperative advanced diffusion magnetic resonance imaging (dMRI).

Materials and methods

48 patients with lower-grade gliomas (23 recurrence, 25 nonrecurrence) were recruited into this study. Different models of dMRI were reconstructed, including apparent fiber density (AFD), white matter tract integrity (WMTI), diffusion tensor imaging (DTI), diffusion kurtosis imaging (DKI), neurite orientation dispersion and density imaging (NODDI), Bingham NODDI and standard model imaging (SMI). Orthogonal Partial Least Squares-Discriminant Analysis (OPLS-DA) was used to construct a multiparametric prediction model for the diagnosis of postoperative recurrence.

Results

The parameters derived from each dMRI model, including AFD, axon water fraction (AWF), mean diffusivity (MD), mean kurtosis (MK), fractional anisotropy (FA), intracellular volume fraction (ICVF), extra-axonal perpendicular diffusivity (De⊥), extra-axonal parallel diffusivity (De∥) and free water fraction (fw), showed significant differences between nonrecurrence group and recurrence group. The extra-axonal perpendicular diffusivity (De⊥) had the highest area under curve (AUC = 0.885), which was significantly higher than others. The variable importance for the projection (VIP) value of De⊥ was also the highest. The AUC value of the multiparametric prediction model merging AFD, WMTI, DTI, DKI, NODDI, Bingham NODDI and SMI was up to 0.96.

Conclusion

Preoperative advanced dMRI showed great efficacy in evaluating postoperative recurrence of LrGG and De⊥ of SMI might be a valuable marker.

Introduction

Lower grade gliomas (LrGG) refer to WHO grade II and III gliomas [1]. Compared with glioblastoma (GBM), the prognosis of LrGG is relatively better. However, the probability of postoperative malignant transformation and recurrence is still high due to its invasive growth characteristics [2]. Surgery is still the main treatment for recurrent gliomas, but there still exists a lack of high-level evidence-based medicine for the survival benefits of patients. Therefore, the prediction of postoperative recurrence has a certain significance in clinic, which may provide convenience for neurosurgeons to evaluate the prognosis of patients and to take targeted precautions, such as appropriate expansion of the resection scope and usage of anti-angiogenic drugs [3].

At present, there is no comprehensive method to predict the recurrence of glioma after operation, but previous researches have shown that the main prognostic risk factors of LrGG included age [4], tumor position [4, 5], size [6] and concurrent chemoradiotherapy [7, 8]. Meanwhile, many molecular phenotypes are also important factors leading to poor prognosis of LrGG, such as IDH1 [9], MGMT [10], CDKN2A/B [11,12,13]. Although pathology through surgery or biopsy is the gold standard for obtaining these key molecular phenotypes, this method is not suitable for all types of gliomas because of its invasiveness and tumor heterogeneity. The existing studies focused exclusively on high-grade glioma. Therefore, an accurate and relatively non-invasive in vivo imaging technique that can predict lower-grade glioma recurrence is necessary for optimal management that avoids the risk of reoperation or rebiopsy and related complications.

Diffusion magnetic resonance imaging (dMRI) is a quantitative imaging technique that can detect the microscopic dispersion characteristics of water molecules in tissue. Diffusion tensor imaging (DTI) and diffusion-kurtosis imaging (DKI) metrics have been used for differentiating tumor recurrence from treatment effects [14, 15]. However, the diagnostic performance of DTI for determining treatment response has been shown to be inconsistent in various studies [16, 17], and some have found that DKI metrics do not appear to provide additional prognostic value compared to other imaging techniques [18, 19]. Recently, novel diffusion MRI techniques, such as the neurite orientation dispersion and density imaging (NODDI) and standard model imaging (SMI) have emerged as powerful tools to evaluate brain microstructure in vivo, as they can provide new insights into the complexity and inhomogeneity of brain microstructure [20, 21]. NODDI metrics have shown promising results in grading of gliomas, assessment of IDH mutation status and monitoring treatment response [22, 23]. However, the value of SMI and NODDI for predicting lower-grade glioma recurrence is unclear. In addition, White Matter Tract Integrity (WMTI) metric, such as axonal water fraction (AWF) is defined as the ratio of intra-axonal water to the sum of intra-axonal water and extra-axonal water which provide more specific insights about tumor physiology [24, 25]. Meanwhile, apparent fiber density (AFD), a dMRI framework to provide a relative measure of the intra-axonal volume of each tract within a voxel, has been used in numerous applications including gliomas. However, to our knowledge, there have no reports on comparison the multiple diffusion models for predicting postoperative recurrence of LrGG via Orthogonal Partial Least Squares-Discriminant Analysis (OPLS-DA).

Therefore, the purpose of this study is to explore the value of preoperative advanced dMRI (AFD, WMTI, DTI, DKI, NODDI, and SMI) in evaluating the postoperative recurrence of LrGG.

Methods

Patient Population

This retrospective study was approved by local ethics committee and written informed consent was waived from all subjects. Patients were included in the study if they met the following inclusion criteria: (a) pathologically confirmed primary LrGG; (b) preoperative dMRI acquisition was performed; (c) initial lesion has received grossly total resection; (d) MRI imaging of patients two years after surgery was available. The following were exclusion criteria: (a) lack of routine MRI imaging; (b) initial lesion hasn’t been total resected; (c) MRI imaging after surgery was not available; (d) head trauma or other neurological diseases existed. Any tumor progression could be established radiologically (follow-up imaging), clinically, or histologically. 7 patients were assessed based on imaging alone, refer to Response Assessment in Neuro-Oncology (RANO) criteria, the criteria of recurrence was the new enhancing component within or without surgery area, there is a lesion diameter increase of ≥ 25%, or/and clinical deterioration or new neurological deficits. From November 2013 to January 2020, a total of 169 patients meeting the above criteria were enrolled in this study. 42 cases lack of routine MRI imaging, 3 cases without complete resection and 76 cases without after surgery MRI imaging were excluded. In total, 48 patients were recruited into this study.

Imaging Data Acquisition

All MR images were performed on the a 3T MR system (Discovery MR750, GE Medical Systems, Milwaukee, WI, United States) with a 32-channel head coil. Routine axial sequences include T1 fluid-attenuated inversion recovery (FLAIR), T2 FLAIR, T2 fast spin echo (FSE) and contrast-enhanced T1 (T1-CE). Before the injection of contrast agents, DKI was performed by spin-echo echo planar imaging (SE-EPI) with 3 b-values (b = 0, 1,250, and 2,500s/mm2) and 25 uniformly distributed directions for each nonzero b-value, TR/TE = 6,500/85, NEX = 1, matrix = 128 × 128, slice thickness = 3 mm, spacing = 0 mm, FOV = 240 mm × 240 mm, acquisition time was 5 min 45 s.

Model Reconstruction

After head motion correction, eddy current correction, bias field correction and brain extraction, several models of dMRI were reconstructed, including apparent fiber density (AFD), axon water fraction (AWF), diffusion tensor imaging (DTI), diffusion kurtosis imaging (DKI), neurite orientation dispersion and density imaging (NODDI), Bingham NODDI and standard model imaging (SMI). SMI model was calculated from https://github.com/NYU-DiffusionMRI/SMI.

The parametric map of DTI was calculated using the data collected by DKI with b = 0 and 1250s/mm2. The model was based on Gaussian distribution, and the formula was as follows [26]:

$$\:FA=\sqrt{\frac{{\left({\lambda\:}_{1}-{\lambda\:}_{2}\right)}^{2}+{\left({\lambda\:}_{1}-{\lambda\:}_{3}\right)}^{2}+{\left({\lambda\:}_{2}-{\lambda\:}_{3}\right)}^{2}}{2\left({\lambda\:}_{1}^{2}+{\lambda\:}_{2}^{2}+{\lambda\:}_{3}^{2}\right)}}$$
(1)
$$\:MD= ({\lambda\:}_{1}+{\lambda\:}_{2}+{\lambda\:}_{3})/3$$
(2)

While \(\:AD={\lambda\:}_{1}\), \(\:RD= ({\lambda\:}_{2}+{\lambda\:}_{3})/2\). Derived parameters included axial diffusivity (AD), mean diffusivity (MD), radial diffusivity (RD) and fractional anisotropy (FA).

Based on non-Gaussian distribution, DKI was obtained using following formula:

$$\:\frac{S\left(b\right)}{S\left(0\right)}=\text{e}\text{x}\text{p}(-b\cdot\:{D}_{app}+1/6{b}^{2}\cdot\:{D}_{app}^{2}\cdot\:{K}_{app})$$
(3)

\(\:{D}_{app}\) referred to apparent diffusion coefficient, \(\:{K}_{app}\) referred to apparent diffusion kurtosis. Derived parameters included axial kurtosis (AK), mean kurtosis (MK) and radial kurtosis (RK).

NODDI was processed based on Watson and Gaussian distribution, and the formula was as follow:

$$\:S=\left(1-{V}_{iso}\right)\left({V}_{ic}{S}_{ic}+\left(1-{V}_{ic}\right){S}_{ec}\right)+{V}_{iso}{S}_{iso}$$
(4)

Derived parameters included intracellular volume fraction (ICVF) and orientation dispersion index (ODI). Similarly, Bingham NODDI has been calculated based on the assumption that the way of water molecular motion measured up Bingham distribution, and the derived parameters included Bin-ICVF, Bin-ODI and dispersion anisotropy index (DAI) [27].

Based on non-Gaussian distribution, SMI was obtained using following formula [21]:

$$\:S\left(\varvec{B}\right)={s}_{0}{\int\:}_{{\mathbb{S}}^{2}}d\widehat{\varvec{n}}\mathcal{P}\left(\widehat{\varvec{n}}\right)\mathcal{K}(b,\beta\:,\widehat{\varvec{n}}\cdot\:\widehat{\varvec{u}})$$
(5)

\(\:\mathcal{P}\left(\widehat{\varvec{n}}\right)\) represented orientation distribution function (ODF) and \(\:\mathcal{K}\:(b,\:\beta\:,\widehat{\varvec{n}}\cdot\:\widehat{\varvec{u}})\) represented response kernel coded by B-tensor. Derived parameters included axonal diffusivity (Da), extra-axonal parallel diffusivity (De∥), extra-axonal perpendicular diffusivity (De⊥), fraction (f) and free water fraction (fw).

According to fiber orientation distribution function (fODF), AFD was calculated in Tractflow [28], the derived parameters included AFD-sum, AFD-total and AFD-max. In addition, AWF map was obtained by using white matter tract integrity (WMTI).

Region of Interest Analysis

Under the premise that researchers were blinded to clinical characteristics, five to eight regions of interest (ROIs) ranging from 80 to 110 pixels were manually placed in the solid parts of tumor parenchyma avoiding hemorrhage, calcification, edema, necrosis and cystic lesions. The diameter of ROIs is 6.0 mm. The solid part of tumor parenchyma was defined as the area of enhancement on T1-CE. For cases with very subtle enhancement, we placed ROIs in high signal intensity area in DWI imaging and T2 FLAIR. We put ROIs for standardizing from the contralateral healthy white matter of the brain, the diameter of ROIs was also 6.0 mm. Then, ROI was copied to each parametric map and the derived parameters value from all ROIs for each patient were recorded for later analysis.

Statistic analysis

Chi-square tests or R × C columnar tables were used to test categorical variables. According to the normality of continuous variables, t-test was used when data emerged on normal distribution while Mann–Whitney U test was used to analyze data emerging on non-normal distribution. Receiver operating characteristic (ROC) curves were performed to evaluate the diagnostic efficacy of each parameter. And area under the curve (AUC) value was compared by Z test. Orthogonal partial least squares-discriminant analysis (OPLS-DA) was used to construct a multiparametric prediction model with variable importance for the projection (VIP) of each parameter been calculated. All statistical analysis was performed with SPSS (Version 19.0.0, IBM, Armonk, NY, United States), MedCalc (Version 15.8, MedCalc Software, Acacialaan, Ostend, Belgium) and SIMCA (Version 14.1.0.2047, MSK, Umetrics, AB). P < 0.05 was considered statistically significant.

Results

Clinical characteristics and routine MRI features

A total of 48 LrGG patients were enrolled, including 25 non-recurrence cases and 23 recurrence cases. The differences in lesion margin (P = 0.010) and pathological grading (P = 0.020) between two groups were statistically significant (Table 1).

Table 1 Clinical characteristics and routine MRI features

Assessment of Postoperative recurrence of LrGG by Advanced dMRI

Figures 1 and 2 showed the preoperative T1-CE, T2 FLAIR and dMRI derived parametric maps of typical recurrence and non-recurrence case. Compared with cases in non-recurrence group, cases in recurrence group showed significantly higher AFD-max, AFD-sum, AFD-total, AWF, FA, AK, MK, RK, Bin-ICVF, ICVF, De∥ as well as f values (P < 0.05) and lower AD, MD, RD, De⊥ as well as fw values (P < 0.05). Nevertheless, there were no significant differences in Bin-DAI, Bin-ODI, ODI and Da values (P = 0.959, 0.709, 0.842, 0.543, respectively) between two groups (Fig. 3).

Fig. 1
figure 1

(A1-A10) Correspond to a 48-year-old female patient with astrocytoma (WHO Grade II) who didn’t experience postoperative recurrence within two years after resection. The AFD-total, AWF, FA, MK as well as ICVF maps showed decreased values in the solid part of the tumor (indicated by the red arrow), while MD and De⊥ maps showed increased values. No significant difference was observed in the Bin-DAI map

Fig. 2
figure 2

(B1-B10) Correspond to a 51-year-old female patient with astrocytoma (WHO Grade III) who experienced postoperative recurrence within two years after resection. Compared with Fig. 1, the AFD-total, AWF, FA, MK as well as ICVF maps showed increased values in the solid part of the tumor (indicated by the red arrow), while MD and De⊥ maps showed decreased values. The difference in Bin-DAI was also not significant

Fig. 3
figure 3

Bar and plots of parameters. Bar represented the mean values while plot extending represented standard deviation. y-axis represents the value of each parameter. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001; ns, no significance

Table 2 showed the AUC values and its 95% confidence interval (95% CI), sensitivity as well as specificity values for discriminating whether patients with LrGG occurred recurrence within two years after resection. AFD-max, De⊥ and fw showed considerable diagnostic efficacy in prediction (AUC > 0.8) while AFD-sum, AFD-total, AWF, MD, RD, FA, AK, MK, RK, Bin-ICVF and ICVF showed acceptable diagnostic efficacy (AUC > 0.7). However, AD, De∥and f were limited in diagnosis (AUC < 0.7). De⊥ had the highest diagnostic efficacy and was significantly higher than those of De∥, f, RD, MK, Bin-ICVF and ICVF (P = 0.002, 0.009, 0.040, 0.040, 0.020, 0.020, respectively). The ROC results of Bin-DAI, Bin-ODI, ODI and Da were not applicable for the reason that these parameters showed no significant difference between two groups.

Table 2 ROC results of dMRI in discriminating recurrence after resection in LrGG

There existed some relative correlation between dMRI derived parameters from different reconstruction models. For example, AWF and f had a strong positive correlation (Fig. 4). Figure 5 showed the results of OPLS-DA. Under comprehensive consideration of the correlation of various parameters, the multiparametric prediction model had great ability to diagnose postoperative recurrence in LrGG with its AUC value up to 0.96. The R2Y score of 0.581 and Q2Y score of 0.422 demonstrated acceptable model interpretability and predictability. Additionally, the results in 200 times permutation tests were consistently lower than the original R2Y and Q2Y values, with the intercepts of R2Y and Q2Y under 0.3 and 0.05, respectively. These suggested that the model fitted well without overfitting. Furthermore, several parameters were found to be valuable markers with their VIP values more than 1 on the premise that they showed significantly differences between groups (P < 0.05). The parameters in descending order of VIP values included De⊥, AFD-total, AFD-sum, AFD-max, RK, De∥, MK, ICVF and Bin-ICVF.

Fig. 4
figure 4

Correlation heatmap of various dMRI derived parameters. Red checks represented positive correlation while blue checks represented negative correlation. The more obvious the color was, the stronger correlation existed

Fig. 5
figure 5

The results of OPLS-DA. A score scatter plot, green dots and blue dots are located on both sides of the y-axis respectively which means model reconstructed by OPLS-DA under comprehensive consideration of the correlation of various parameters can effectively distinguish two groups.; (B) 200 times permutation tests, this test aimed to prove whether model was overfitting. The results were consistently lower than the original R2Y and Q2Y values, with the intercepts on y-axis of R2Y and Q2Y under 0.3 and 0.05, respectively which suggested that the model fitted well without overfitting; (C) VIP plot, The variable importance for the projection(VIP) means the importance of parameters in identifying different groups, VIP value more than 1 indicates that the parameter is significant and the higher the VIP value, the greater the importance of the parameter in distinguishing between different groups. ; (D) ROC curve of multiparametric prediction model

Discussion

Our study discussed the application of advanced dMRI in predicting the postoperative recurrence of LrGG within two years after resection. The results showed that the lesion margin obtained from T2 FLAIR may helpful to assess the postoperative recurrence. AFD, AWF, DTI, DKI, Bingham NODDI, NODDI and SMI reconstruction models can provide valuable parameters for prediction. Among them, De⊥ showed the highest diagnostic efficiency and was significantly higher than others. In the further OPLS-DA, De⊥ also had the highest VIP value, and the multiparametric prediction model with comprehensive consideration of the correlation of various parameters had great diagnostic performance.

There have been no conclusive researches on the mechanism of glioma recurrence. By exome sequencing, Brett found that some gene mutations such as TP53 and ARTX were not detected in recurrent tumors compared to primary tumors in low grade gliomas [29]. Similarly, research focused on genomic analysis of primary and recurrent GBM indicated that there existed subclone alterations between them [30]. In addition, in the study of tumor microenvironment, researchers have found that there are differences in the immunological composition of extracellular tumor microenvironment between primary and recurrent GBM, with a decrease in invasive mononuclear cells and an increase in macrophages/microglia in recurrent GBM [31]. On the other hand, cancer stem cells (CSCs), as important roles, also participated in the process of tumor growth, metastasis and recurrence. Chen proposed that CSC would re-enter the cell cycle after treatment with temozolomide. Sequential administration of ganciclovir plus temozolomide to eliminate CSC could improve the survival of GBM mice, demonstrating the importance of CSC in mediating glioma recurrence after treatment [32]. These differences in transcriptome, genome, tumor microenvironment as well as the existence of CSCs suggested that recurrent gliomas had unique molecular biological characteristics. For patients with gliomas who may occur postoperative recurrence, the primary lesions may have specific imaging manifestations.

On T2 FLAIR imaging, differences were found in preoperative imaging between non-recurrence and recurrence groups. Specifically, lesions margin of non-recurrence group appeared sharper, while those of recurrence group appeared more blurred. Previous studies have shown that tumor cells of gliomas can migrate through white matter fiber bundles in the tumor parenchyma or peritumoral edema area, resulting in invasive growth or local metastasis and recurrence [33,34,35]. In this study, compared with cases in non-recurrence group, lesion margins of gliomas in recurrence group appeared more blurred for the reason that these lesions existed relatively severe peritumoral edema. And the characteristic of tumor aggressive growth was more obvious, which therefore leading them more likely to occur recurrence within two years after operation. The blurred boundary of gliomas is mainly caused by the following reasons: First, strong invasiveness of tumor cells: glioma cells can spread widely in normal brain tissue, so the boundary between tumor and normal brain tissue is not obvious. Then, the cellular heterogeneity within the glioma makes it difficult to distinguish part of the tumor area from the surrounding normal tissue. And more, the location and shape of the tumor are changeable, gliomas can occur anywhere in the brain and have a variety of forms, which further aggravates the difficulty of definition. The unclear tumor boundary has the following effects on the treatment and prognosis of glioma: surgical resection is difficult: surgery is one of the common methods for the treatment of glioma, but because of the unclear boundary, it is extremely difficult to remove the tumor completely. Residual tumor cells are an important cause of recurrence [36]. The difficulty of localization of radiotherapy and chemotherapy: treatment planning requires accurate tumor location to maximize efficacy and reduce damage to normal brain tissue. Unclear boundaries pose a challenge to treatment planning [37]. In addition, we found that the pathological grade of gliomas in non-recurrence group was higher than that in recurrence group. Postoperative recurrence of LrGG involves complex pathological processes that are not solely dependent on the initial pathological grade [1, 38]. Factors such as tumor microenvironment, CSCs, and genetic mutations play significant roles in recurrence. Research indicates that CSCs, which possess the ability to self-renew and drive tumor growth, can re-enter the cell cycle after treatment, contributing to tumor recurrence. Gliomas with a higher initial grade might have undergone more aggressive treatment, reducing the population of CSCs and thus lowering the recurrence rate. Additionally, recurrent gliomas often exhibit changes in their microenvironment, which might not be directly related to the initial pathological grade but rather to the dynamic interactions within the tumor and its surroundings. Moreover, gliomas are heterogeneous, and molecular characteristics can vary significantly even within the same pathological grade. Factors such as IDH1 mutation status, MGMT promoter methylation, and CDKN2A/B status can influence tumor behavior and recurrence risk independently of histological grade, which can affect recurrence patterns. Gliomas with a higher pathological grade might receive more aggressive treatment regimens, including extensive surgical resection, higher doses of radiotherapy, and more potent chemotherapeutic protocols. These treatments could effectively reduce the tumor burden and eliminate cells with high recurrence potential. In contrast, lower-grade gliomas might receive less aggressive treatment, leaving behind cells with a higher likelihood of recurrence due to incomplete eradication of invasive cells or CSCs.

According to previous studies, gliomas with postoperative recurrence potential had their own characteristics at genomic and transcriptome level, molecular and cellular level in tumor microenvironment. These characteristic manifestations were likely to result in macroscopic imaging features changes which were difficult to be reflected on conventional MRI structural imaging because of the low resolution. Advanced dMRI reflected the microscopic motion of water molecules, containing structural characteristic information of white matter fiber bundles, and could provide microstructure information which cannot be reflected by traditional MRI. dMRI has been widely used in clinical research and assessment of treatment response in gliomas [14, 16, 23, 39]. Therefore, this study assumed that gliomas with and without recurrence potential had different imaging manifestations on dMRI, and various reconstruction models had their own advantages. The establishment of a reasonable prediction model after taking fully account of the correlation between multiple models and their derived parameters will be helpful in predicting the postoperative recurrence of LrGG.

Based on fODF, AFD characterized the axonal density, which could analyze fiber bundle information within voxels [40]. The increase in AFD value in a sense reflected the increase of the number or volume of axons. AWF, derived from WMTI, was defined as the ratio of water inside the axon to the sum of water inside and outside the axon [41]. Similar to AFD, the increase in AWF value indicated an increase in axonal density and limited diffusion of water molecules. In this study, the preoperative AFD and AWF values of LrGG with postoperative recurrence were significantly higher than those of LrGG without postoperative recurrence. This finding might be due to the fact that LrGG with potential of recurrence exhibited more aggressive and malignant biological behavior. The accumulation of axons within the unit voxel in tumor parenchyma leaded to the reduction of extra-axonal space, and the complex structure of white matter fiber bundles restricted the dispersion of water molecules, resulting in an increase in AFD and AWF values.

Besides, for DTI and DKI, the preoperative MD value in recurrence group was significantly lower than that in non-recurrence group, while FA and MK values were higher. We suggested that the growth of glioma in recurrence group was more invasive and the tumor cells grown relatively faster, which resulted in the smaller extracellular space. Thus, the diffusion of water molecules in microenvironment became limited, which may explain the significantly lower MD value compared with non-recurrence group. FA represented the integrity and orientation of white matter fiber bundle, which had some correlation with cell proliferation and density [42, 43]. The more aggressive malignant growth pattern of gliomas in recurrence group propelled the increase in FA value. In a previous study, researchers found that for non-enhanced peritumoral region (NEPTR) of GBM, preoperative FA values in areas with postoperative recurrence were significantly lower than those in areas without recurrence [44]. NEPTR on T2 FLAIR mainly contained angiogenic edema and possible tumor cell infiltration. Previous researchers thought that there was a significant negative correlation between FA and tumor cell infiltration [43], which might due to the decrease of extracellular space and isotropic diffusion. Therefore, FA value of areas with recurrence potential in NEPTR would be significantly lower than those without recurrence potential, which was not inconsistent with the results of this study.

Previous research explore the use of DTI to identify patterns that predict glioma recurrence. It highlights the potential of DTI parameters like FA to delineate areas at risk for recurrence based on their diffusion properties, indicating that these techniques could provide valuable insights into the structural and pathological nature of gliomas [39]. Another research imaged 26 patients with gliomas using DTI. Patients were imaged after 2 years or on symptomatic tumor recurrence. The diffusion tensor was split into its isotropic (p) and anisotropic (q) components, and these were plotted on T(2)-weighted images to show the pattern of DTI abnormality. This was compared to the pattern of recurrence. Diffusion tensor imaging is able to predict patterns of tumor recurrence [45]. And more, researchers evaluate diffusion-proliferation models informed by structural MRI and DTI, after tumor resection. They applied the models to a unique longitudinal dataset of 14 patients with LGG, who received no treatment after surgical resection, to predict the recurrent tumor shape after tumor resection. The DTI-informed model reached the best predictive performance. There is a significant improvement in the prediction of the recurrent tumor shape when using a DTI-informed anisotropic diffusion model with respect to istropic diffusion [46]. Like our study, they found high diagnostic efficacy of these imaging markers in assessing tumor recurrence potential, multiple dMRI metrics including DTI were employed to distinguish between recurrent and non-recurrent gliomas. These findings align with our research, underscoring the effectiveness of sophisticated MRI techniques, including DTI and other dMRI metrics, in predicting glioma recurrence. This validation from multiple studies highlights the relevance of advanced imaging techniques in improving the prognosis assessment and potentially guiding treatment strategies for glioma patients.

In addition, for Bingham NODDI and NODDI, values of Bin-ICVF and ICVF in recurrence group were higher. ICVF was defined as intracellular volume fraction, which represented the density of axons. The higher the density of glioma cells, the higher the ICVF value in recurrence group. Bin-DAI and ODI, which indicated the degree of water dispersion limitation didn’t show significant difference between groups. This might be due to the fact that the establishment of NODDI model was not sensitive to the prediction of postoperative recurrence of LrGG, which needed further confirm. For SMI, the recurrence group had higher De∥ and f values and lower De⊥ and fw values, while the difference in Da between groups was not statistically significant. The more malignant growth pattern of gliomas in recurrence group made the destruction of white matter fiber bundles more serious and the tumor microenvironment more complex, which might be the reason for the increase of axonal signal fraction, f. The reduced De⊥ value indicated the decrease of the extra-axonal space, and the dispersion of water molecules in the vertical axon direction was relatively limited, which was probably caused by the increase of tumor cell density in recurrence group. However, De∥ ascended in recurrence group, which meant that the dispersion of water molecules in the parallel axon direction was relatively unrestricted.

Moreover, in order to explore the predictive ability of various derived parameters of dMRI for postoperative recurrence of LrGG, the results of ROC analysis showed that except for the limited diagnostic efficiency of AD and De∥ (AUC < 0.7), other parameters had great diagnostic efficacy, among which AFD-max, De⊥ and fw had considerable diagnostic efficiency (AUC > 0.8). De⊥ performed best (AUC = 0.885), which was significantly higher than others. Although a single parameter alone showed great diagnostic efficiency, the reconstruction models and their derived parameters were obtained from the same original dMRI data, which leaded to some correlation among parameters. For example, there existed a strong positive correlation between AWF representing axon water fraction and f representing axonal signal fraction. It is necessary to comprehensively consider the correlation among the parameters in order to improve the diagnostic efficiency and reduce the diagnostic error. Therefore, in this study, a multiparametric prediction model was established by using OPLS-DA method. Compared with a single parameter alone, its prediction efficiency for postoperative recurrence of LrGG was improved to 0.96. The variable importance for the projection (VIP) value of De⊥ was the highest. Regardless of the predictive ability of a single derived parameter or the evaluation of VIP in multiparametric prediction model, De⊥ exhibited the best performance, suggesting that De⊥ was likely to become a valuable imaging marker for predicting postoperative recurrence of LrGG.

This study still had some limitations. First of all, this study only conducted in one medical institution, the number of cases was relatively small, and the adoption of retrospective research lacked prospective validation. In future, data from multiple centers and large samples will be needed to verify the effectiveness of dMRI in predicting postoperative recurrence of gliomas. In addition, the molecular biological characteristics such as IDH1 genotype and MGMT promoter methylation status had not been subdivided in analysis and these genotypic or epigenetic differences might also affect postoperative recurrence. This study will continue to analyze and explore different subgroups of molecular biological characteristics of LrGG.

AFD, AWF, DTI, DKI, Bingham NODDI, NODDI and SMI models of advanced dMRI had great performance in evaluating the recurrence of LrGG within two years after operation. The derived parameter of SMI model, De⊥, had the best diagnostic effectiveness and was significantly better than others. The information such as lesion margin provided by traditional MRI was also helpful to predict postoperative recurrence. The combination of multiparametric advanced dMRI information will make convenient for diagnosing as well as making clinical decisions, such as appropriate expansion of the resection scope and preventive use of anti-angiogenic drugs and so on, which had certain clinical significance.

Availability of data materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Data availability

No datasets were generated or analysed during the current study.

Abbreviations

IDH1:

isocitrate dehydrogenase 1

LrGG:

lower-grade glioma

DTI:

diffusion tensor imaging

DKI:

diffusion kurtosis imaging

WMTI:

white matter tract integrity

NODDI:

neurite orientation dispersion and density imaging

AFD:

apparent fiber density

SMI:

standard model imaging

FA:

fractional anisotropy

MD:

mean diffusivity

AD:

axial diffusivity

RD:

radial diffusivity

MK:

mean kurtosis

AK:

axial kurtosis

RK:

radial kurtosis

ICVF:

intra-cellular volume fraction

AWF:

axonal water fraction

OPLS-DA:

Orthogonal Partial Least Squares-Discriminant Analysis

References

  1. Research NCGA, Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, et al. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas. N Engl J Med. 2015;372(26):2481–98.

    Article  Google Scholar 

  2. Murphy ES, Leyrer CM, Parsons M, Suh JH, Chao ST, Yu JS, et al. Risk factors for malignant transformation of low-grade glioma. Int J Radiat Oncol Biol Phys. 2018;100(4):965–71.

    Article  PubMed  Google Scholar 

  3. Wick W, Platten M, Wick A, Hertenstein A, Radbruch A, Bendszus M, et al. Current status and future directions of anti-angiogenic therapy for gliomas. Neuro Oncol. 2016;18(3):315–28.

    Article  PubMed  CAS  Google Scholar 

  4. Zhao YY, Chen SH, Hao Z, Zhu HX, Xing ZL, Li MH. A nomogram for predicting individual prognosis of patients with low-grade glioma. World Neurosurg. 2019;130:e605-612.

    Article  PubMed  Google Scholar 

  5. Yahanda AT, Patel B, Shah AS, Cahill DP, Sutherland G, Honeycutt J, et al. Impact of intraoperative magnetic resonance imaging and other factors on surgical outcomes for newly diagnosed grade II astrocytomas and oligodendrogliomas: a multicenter study. Neurosurgery. 2020;88(1):63–73.

    Article  PubMed  Google Scholar 

  6. Liu H, Shen L, Huang X, Zhang G. Maximal tumor diameter in the preoperative tumor magnetic resonance imaging (MRI) T2 image is associated with prognosis of grade II. Glioma Med (Baltimore). 2021;100(10):e24850.

    Article  CAS  Google Scholar 

  7. Liu Y, Liu S, Li G, Li Y, Chen L, Feng J, et al. Association of high-dose radiotherapy with improved survival in patients with newly diagnosed low-grade gliomas. Cancer. 2022;128(5):1085–92.

    Article  PubMed  CAS  Google Scholar 

  8. Wei S, Li J. (2022) Efficacy and Safety of Temozolomide Combined with Radiotherapy in the Treatment of Malignant Glioma. J Healthc Eng, 2022(3477918.

  9. Kizilbash SH, Giannini C, Voss JS, Decker PA, Jenkins RB, Hardie J, et al. The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma. J Neurooncol. 2014;120(1):85–93.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Wei J, Yang G, Hao X, Gu D, Tan Y, Wang X, et al. A multi-sequence and habitat-based MRI radiomics signature for preoperative prediction of MGMT promoter methylation in astrocytomas with prognostic implication. Eur Radiol. 2019;29(2):877–88.

    Article  PubMed  Google Scholar 

  11. Appay R, Dehais C, Maurage CA, Alentorn A, Carpentier C, Colin C, et al. CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neurooncology. 2019;21(12):1519–28.

    CAS  Google Scholar 

  12. Lu VM, O’connor KP, Shah AH, Eichberg DG, Luther EM, Komotar RJ, et al. The prognostic significance of CDKN2A homozygous deletion in IDH-mutant lower-grade glioma and glioblastoma: a systematic review of the contemporary literature. J Neurooncol. 2020;148(2):221–9.

    Article  PubMed  CAS  Google Scholar 

  13. Shirahata M, Ono T, Stichel D, Schrimpf D, Reuss DE, Sahm F, et al. Novel, improved grading system(s) for IDH-mutant astrocytic gliomas. Acta Neuropathol. 2018;136(1):153–66.

    Article  PubMed  CAS  Google Scholar 

  14. Wu XF, Liang X, Wang XC, Qin JB, Zhang L, Tan Y, et al. Differentiating high-grade glioma recurrence from pseudoprogression: comparing diffusion kurtosis imaging and diffusion tensor imaging. Eur J Radiol. 2021;135:109445.

    Article  PubMed  Google Scholar 

  15. Xu JL, Li YL, Lian JM, Dou SW, Yan FS, Wu H, et al. Distinction between postoperative recurrent glioma and radiation injury using MR diffusion tensor imaging. Neuroradiology. 2010;52(12):1193–9.

    Article  PubMed  Google Scholar 

  16. Sundgren PC, Fan X, Weybright P, Welsh RC, Carlos RC, Petrou M, et al. Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging. 2006;24(9):1131–42.

    Article  PubMed  CAS  Google Scholar 

  17. Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P, Papadopoulos A, et al. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma. Magn Reson Imaging. 2014;32(7):854–9.

    Article  PubMed  CAS  Google Scholar 

  18. Chakhoyan A, Woodworth DC, Harris RJ, Lai A, Nghiemphu PL, Liau LM, et al. Mono-exponential, diffusion kurtosis and stretched exponential diffusion MR imaging response to chemoradiation in newly diagnosed glioblastoma. J Neurooncol. 2018;139(3):651–9.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Baek HJ, Kim HS, Kim N, Choi YJ, Kim YJ. Percent change of perfusion skewness and kurtosis: a potential imaging biomarker for early treatment response in patients with newly diagnosed glioblastomas. Radiology. 2012;264(3):834–43.

    Article  PubMed  Google Scholar 

  20. Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. NODDI: practical in vivo neurite orientation dispersion and density imaging of the human brain. NeuroImage. 2012;61(4):1000–16.

    Article  PubMed  Google Scholar 

  21. Coelho S, Baete SH, Lemberskiy G, Ades-Aron B, Barrol G, Veraart J, et al. Reproducibility of the Standard Model of diffusion in white matter on clinical MRI systems. NeuroImage. 2022;257: 119290.

    Article  PubMed  Google Scholar 

  22. Zhao J, Li JB, Wang JY, Wang YL, Liu DW, Li XB, et al. Quantitative analysis of neurite orientation dispersion and density imaging in grading gliomas and detecting IDH-1 gene mutation status. Neuroimage Clin. 2018;19:174–81.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Onishi R, Sawaya R, Tsuji K, Arihara N, Ohki A, Ueda J, et al. Evaluation of temozolomide treatment for glioblastoma using amide proton transfer imaging and diffusion MRI. Cancers. 2022;14(8):1907.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Benitez A, Jensen JH, Falangola MF, Nietert PJ, Helpern JA. Modeling white matter tract integrity in aging with diffusional kurtosis imaging. Neurobiol Aging. 2018;70:265–75.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Margoni M, Petracca M, Schiavi S, Fabian M, Miller A, Lublin FD, et al. Axonal water fraction as marker of white matter injury in primary-progressive multiple sclerosis: a longitudinal study. Eur J Neurol. 2019;26(8):1068–74.

    Article  PubMed  CAS  Google Scholar 

  26. Xie Y, Li S, Shen N, Gan T, Zhang S, Liu WV, et al. Assessment of Isocitrate dehydrogenase 1 genotype and cell proliferation in Gliomas using multiple diffusion magnetic resonance imaging. Front NeuroSci. 2021;15: 783361.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Tariq M, Schneider T, Alexander DC, Gandini Wheeler-Kingshott CA, Zhang H. Bingham-NODDI: mapping anisotropic orientation dispersion of neurites using diffusion MRI. Neuroimage. 2016;133:207–23.

    Article  PubMed  Google Scholar 

  28. Theaud G, Houde JC, Bore A, Rheault F, Morency F, Descoteaux M. TractoFlow: a robust, efficient and reproducible diffusion MRI pipeline leveraging nextflow & singularity. Neuroimage. 2020;218:116889.

    Article  PubMed  Google Scholar 

  29. Johnson BE, Mazor T, Hong C, Barnes M, Aihara K, Mclean CY, et al. Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma. Science. 2014;343(6167):189–93.

    Article  PubMed  CAS  Google Scholar 

  30. Kim J, Lee IH, Cho HJ, Park CK, Jung YS, Kim Y, et al. Spatiotemporal evolution of the primary glioblastoma genome. Cancer Cell. 2015;28(3):318–28.

    Article  PubMed  CAS  Google Scholar 

  31. Wang Q, Hu B, Hu X, Kim H, Squatrito M, Scarpace L, et al. Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment. Cancer Cell. 2017;32(1):42-e5646.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Chen J, Li Y, Yu TS, Mckay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522–6.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Seow P, Hernowo AT, Narayanan V, Wong JHD, Bahuri NFA, Cham CY, et al. Neural fiber integrity in high- versus low-grade glioma using probabilistic fiber tracking. Acad Radiol. 2021;28(12):1721–32.

    Article  PubMed  Google Scholar 

  34. Stikov N, Campbell JS, Stroh T, Lavelée M, Frey S, Novek J et al. (2015) In vivo histology of the myelin g-ratio with magnetic resonance imaging. Neuroimage, 118(397–405.

  35. Sahm F, Capper D, Jeibmann A, Habel A, Paulus W, Troost D, et al. Addressing diffuse glioma as a systemic brain disease with single-cell analysis. Arch Neurol. 2012;69(4):523–6.

    Article  PubMed  Google Scholar 

  36. Hoggarth AR, Muthukumar S, Thomas SM, Crowley J, Kiser J, Witcher MR. (2024) Clinical Theranostics in Recurrent Gliomas: A Review. Cancers (Basel), 16(9).

  37. Nie S, Zhu Y, Yang J, Xin T, Xue S, Zhang X, et al. Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging. Radiat Oncol. 2021;16(1):97.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, et al. Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet. 2015;47(5):458–68.

    Article  PubMed  CAS  Google Scholar 

  39. Metz MC, Molina-Romero M, Lipkova J, Gempt J, Liesche-Starnecker F, Eichinger P, et al. Predicting glioblastoma recurrence from preoperative MR scans using fractional-anisotropy maps with free-water suppression. Cancers. 2020;12(3):728.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Raffelt D, Tournier JD, Rose S, Ridgway GR, Henderson R, Crozier S, et al. Apparent fibre density: a novel measure for the analysis of diffusion-weighted magnetic resonance images. NeuroImage. 2012;59(4):3976–94.

    Article  PubMed  Google Scholar 

  41. Jelescu IO, Budde MD. Design and validation of diffusion MRI models of white matter. Front Phys. 2017;28:61.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Basser PJ, Pierpaoli C. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B. 1996;111(3):209–19.

    Article  PubMed  CAS  Google Scholar 

  43. Stadlbauer A, Ganslandt O, Buslei R, Hammen T, Gruber S, Moser E, et al. Gliomas: histopathologic evaluation of changes in directionality and magnitude of water diffusion at diffusion-tensor MR imaging. Radiology. 2006;240(3):803–10.

    Article  PubMed  Google Scholar 

  44. Bette S, Huber T, Gempt J, Boeckh-Behrens T, Wiestler B, Kehl V, et al. Local fractional anisotropy is reduced in areas with tumor recurrence in glioblastoma. Radiology. 2017;283(2):499–507.

    Article  PubMed  Google Scholar 

  45. Price SJ, Jena R, Burnet NG, Carpenter TA, Pickard JD, Gillard JH. Predicting patterns of glioma recurrence using diffusion tensor imaging. Eur Radiol. 2007;17(7):1675–84.

    Article  PubMed  Google Scholar 

  46. Van Garderen KA, Van Der Voort SR, Wijnenga MMJ, Incekara F, Alafandi A, Kapsas G, et al. Evaluating the predictive value of glioma growth models for low-grade glioma after tumor resection. IEEE Trans Med Imaging. 2024;43(1):253–63.

    Article  PubMed  Google Scholar 

Download references

Funding

This study has received funding by National Natural Science Foundation of China (grant number U22A20354, 82001787), National Key Research and Development Program of China (grant number 2022YFC2406903), and China International Medical Foundation (grant number 2023097).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Luyue Gao and Yuanhao Li provided the overall design of the experiments and contributed equally to the experiments. Hongquan Zhu and Yufei Liu were responsible for the collection of clinical and imaging data. Shihui Li and Li Li completed tumor segmentation. Yuanhao Li and Jiaxuan Zhang performed the statistical analysis. Luyue Gao and Nanxi Shen wrote and edited the manuscript. Wenzhen Zhu supervised the study. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Nanxi Shen or Wenzhen Zhu.

Ethics declarations

Ethics approval and consent to participate

This retrospective study was approved by local ethics committee of our institution. Patient consent was waived due to the retrospective nature of the study.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gao, L., Li, Y., Zhu, H. et al. Application of preoperative advanced diffusion magnetic resonance imaging in evaluating the postoperative recurrence of lower grade gliomas. Cancer Imaging 24, 134 (2024). https://doi.org/10.1186/s40644-024-00782-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40644-024-00782-9

Keywords